SCHEMBL30064525

SCHEMBL30064525

CSCC[C@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CTSS P25774 1/20 0.56
▸ CTSK P43235 1/20 0.56
▸ REN P00797 1/20 0.45
▸ EPHX2 P34913 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ BACE1 P56817 3/20 0.44
▸ TSHR P16473 1/20 0.43
▸ KLK7 P49862 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ GLS O94925 1/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29918303 0.99 CTSS (0.55) CTSSCTSKRENEPHX2CA2
SCHEMBL29918073 0.91 CTSS (0.56) CTSSCTSKRENCA2BACE1
SCHEMBL27704332 0.89 CTSK (0.64) CTSSCTSKEPHX2CA2TSHR
SCHEMBL27688713 0.89 CTSK (0.64) CTSSCTSKEPHX2CA2TSHR
SCHEMBL27483577 0.89 CTSK (0.64) CTSSCTSKEPHX2CA2TSHR
Hydrochloric Acid SCHEMBL27704331 0.87 CTSK (0.63) CTSSCTSKEPHX2CA2TSHR
SCHEMBL30064531 0.84 CTSS (0.63) CTSSCTSKRENEPHX2CA2
SCHEMBL16462557 0.83 CTSK (0.53) CTSSCTSKRENBACE1KLK7
SCHEMBL16462559 0.83 CTSK (0.53) CTSSCTSKRENBACE1KLK7
SCHEMBL29813491 0.82 CTSK (0.52) CTSSCTSKRENKLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4538279-A2 REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME Chubu University Educational Foundation (JP) 2025-04-16 — — EP disclosed
US-20230121469-A1 CATALYST FOR MANUFACTURING AMIDE COMPOUND, AND METHOD FOR MANUFACTURING AMIDE COMPOUND CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) 2023-04-20 — — US disclosed
US-20230002422-A1 REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) 2023-01-05 — — US disclosed
EP-4053132-A1 REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME Chubu University Educational Foundation (JP) 2022-09-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002422-A1 REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME NAAA, NOTUM, ASNS CTSS 483/4885CTSK 791/4885REN 1158/4885
US-20230121469-A1 CATALYST FOR MANUFACTURING AMIDE COMPOUND, AND METHOD FOR MANUFACTURING AMIDE COMPOUND NAAA, ASNS, BCAT2 CTSS 621/4885CTSK 778/4885REN 573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback